![Merdad Parsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Merdad Parsey
Director/Board Member at
ARRIVENT BIOPHARMA, INC.
Net worth: 216 560 $ as of 31/08/2026
Profile
Dr. Merdad V. Parsey is an Independent Director at Arcus Biosciences, Inc. and a Chief Medical Officer at Gilead Sciences, Inc. He is on the Board of Directors at Arcus Biosciences, Inc. and Sagimet Biosciences, Inc. Dr. Parsey was previously employed as a Senior Medical Director by Regeneron Pharmaceuticals, Inc., a Senior Director-Medical Group by Genentech, Inc., an Associate Medical Director by Merck & Co., Inc., a Director-Critical Care Medicine by New York University School of Medicine, a Member by Roche Group, and a Senior Medical Director by Sunovion Pharmaceuticals, Inc. He received his doctorate degree from the University of Maryland.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC. 0.02% | 16/06/2026 | 57,291 ( 0.02% ) | 216 560 $ | 31/08/2026 |
| 18/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Latest news about Merdad Parsey
Merdad Parsey active positions
| Companies | Position | Start |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Director/Board Member | 28/04/2025 |
| ARDELYX, INC. | Director/Board Member | 28/04/2025 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Director/Board Member | - |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01/09/2026 |
Former positions of Merdad Parsey
| Companies | Position | End |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Chief Executive Officer | 01/01/2019 |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/04/2025 |
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 06/02/2025 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/11/2019 |
| REGENERON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
Training of Merdad Parsey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Gilead Foundation
 Gilead Foundation The Gilead Foundation is a company based in Foster City, CA. | |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland Baltimore County
 University of Maryland Baltimore County Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
- Stock Market
- Insiders
- Merdad Parsey
